US Oncology Investor Relations Manager Salaries in Dallas | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology Investor Relations Manager Salaries in Dallas

The average US Oncology Investor Relations Manager in Dallas earns an estimated $100,006 annually. US Oncology's Investor Relations Manager compensation is $12,702 more than the US average for a Investor Relations Manager.

In Dallas, The Communications Department at US Oncology earns $2,668 more on average than the Enterprise Risk Department.

Last updated 7 months ago.

$51k
$64k
$75k
$85k
$114k
$175k
$100,006
Average Compensation
$100,006
avg. base

Investor Relations Manager Salaries at US Oncology

* estimated salary

Compensation at US Oncology by Department

In Dallas, The Communications Department averages $2,668 more than the Enterprise Risk Department.

Communications
$189,704 Avg. total comp.
Enterprise Risk
$187,036 Avg. total comp.
-$3k
Product
$153,663 Avg. total comp.
-$36k

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to US Oncology reported making $152,500, while the average male Investor Relations Manager at similar sized companies reported making $75,500.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Investor Relations Manager at companies similar size to US Oncology reported making $175,000, while the average Caucasian Investor Relations Manager at similar sized companies reported making $70,250.

How Investor Relations Managers at US Oncology Rate Their Compensation

The majority of Investor Relations Managers at US Oncology believe they're compensated fairly. 50% of Investor Relations Managers at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company